Cargando…
Shared sorrow, shared costs: cost-effectiveness analysis of the Empowerment group therapy approach to treat affective disorders in refugee populations
BACKGROUND: Refugees and asylum seekers (RAS) in Germany need tailored and resource-oriented mental healthcare interventions. AIMS: To evaluate the cost-effectiveness of group psychotherapy for RAS with moderate depressive symptoms. METHOD: This is a post hoc cost-effectiveness analysis of Empowerme...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305100/ https://www.ncbi.nlm.nih.gov/pubmed/37345544 http://dx.doi.org/10.1192/bjo.2023.504 |
_version_ | 1785065653705637888 |
---|---|
author | Strupf, Michael Hoell, Andreas Bajbouj, Malek Böge, Kerem Wiechers, Maren Karnouk, Carine Kamp-Becker, Inge Banaschewski, Tobias Meyer-Lindenberg, Andreas Rapp, Michael Hasan, Alkomiet Falkai, Peter Habel, Ute Heinz, Andreas Plener, Paul Kaiser, Franziska Weigold, Stefanie Mehran, Nassim Übleis, Aline Padberg, Frank |
author_facet | Strupf, Michael Hoell, Andreas Bajbouj, Malek Böge, Kerem Wiechers, Maren Karnouk, Carine Kamp-Becker, Inge Banaschewski, Tobias Meyer-Lindenberg, Andreas Rapp, Michael Hasan, Alkomiet Falkai, Peter Habel, Ute Heinz, Andreas Plener, Paul Kaiser, Franziska Weigold, Stefanie Mehran, Nassim Übleis, Aline Padberg, Frank |
author_sort | Strupf, Michael |
collection | PubMed |
description | BACKGROUND: Refugees and asylum seekers (RAS) in Germany need tailored and resource-oriented mental healthcare interventions. AIMS: To evaluate the cost-effectiveness of group psychotherapy for RAS with moderate depressive symptoms. METHOD: This is a post hoc cost-effectiveness analysis of Empowerment group psychotherapy that was embedded in a stratified stepped and collaborative care model (SCCM) from the multicentre randomised controlled MEHIRA trial. One hundred and forty-nine participants were randomly assigned to SCCM or treatment as usual (TAU) and underwent Empowerment (i.e. level 3 of the SCCM for adults) or TAU. Effects were measured with the nine-item Patient Health Questionnaire (PHQ-9) and quality adjusted life-years (QALY) post-intervention. Health service and intervention costs were measured. Incremental cost-effectiveness ratios (ICER) were estimated and net monetary benefit (NMB) regressions with 95% confidence intervals were performed. Cost-effectiveness was ascertained for different values of willingness to pay (WTP) using cost-effectiveness acceptability curves for probable scenarios. Trial registration number: NCT03109028 on ClinicalTrials.gov. RESULTS: Health service use costs were significantly lower for Empowerment than TAU after 1 year. Intervention costs were on average €409.6. Empowerment led to a significant change in PHQ-9 scores but not QALY. Bootstrapped mean ICER indicated cost-effectiveness according to PHQ-9 and varied considerably for QALY in the base case. NMB for a unit reduction in PHQ-9 score at WTP of €0 was €354.3 (€978.5 to −€269.9). Results were confirmed for different scenarios and varying WTP thresholds. CONCLUSIONS: The Empowerment intervention was cost-effective in refugees with moderate depressive symptoms regarding the clinical outcome and led to a reduction in direct healthcare consumption. Concerning QALYs, there was a lack of confidence that Empowerment differed from TAU. |
format | Online Article Text |
id | pubmed-10305100 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-103051002023-06-29 Shared sorrow, shared costs: cost-effectiveness analysis of the Empowerment group therapy approach to treat affective disorders in refugee populations Strupf, Michael Hoell, Andreas Bajbouj, Malek Böge, Kerem Wiechers, Maren Karnouk, Carine Kamp-Becker, Inge Banaschewski, Tobias Meyer-Lindenberg, Andreas Rapp, Michael Hasan, Alkomiet Falkai, Peter Habel, Ute Heinz, Andreas Plener, Paul Kaiser, Franziska Weigold, Stefanie Mehran, Nassim Übleis, Aline Padberg, Frank BJPsych Open Paper BACKGROUND: Refugees and asylum seekers (RAS) in Germany need tailored and resource-oriented mental healthcare interventions. AIMS: To evaluate the cost-effectiveness of group psychotherapy for RAS with moderate depressive symptoms. METHOD: This is a post hoc cost-effectiveness analysis of Empowerment group psychotherapy that was embedded in a stratified stepped and collaborative care model (SCCM) from the multicentre randomised controlled MEHIRA trial. One hundred and forty-nine participants were randomly assigned to SCCM or treatment as usual (TAU) and underwent Empowerment (i.e. level 3 of the SCCM for adults) or TAU. Effects were measured with the nine-item Patient Health Questionnaire (PHQ-9) and quality adjusted life-years (QALY) post-intervention. Health service and intervention costs were measured. Incremental cost-effectiveness ratios (ICER) were estimated and net monetary benefit (NMB) regressions with 95% confidence intervals were performed. Cost-effectiveness was ascertained for different values of willingness to pay (WTP) using cost-effectiveness acceptability curves for probable scenarios. Trial registration number: NCT03109028 on ClinicalTrials.gov. RESULTS: Health service use costs were significantly lower for Empowerment than TAU after 1 year. Intervention costs were on average €409.6. Empowerment led to a significant change in PHQ-9 scores but not QALY. Bootstrapped mean ICER indicated cost-effectiveness according to PHQ-9 and varied considerably for QALY in the base case. NMB for a unit reduction in PHQ-9 score at WTP of €0 was €354.3 (€978.5 to −€269.9). Results were confirmed for different scenarios and varying WTP thresholds. CONCLUSIONS: The Empowerment intervention was cost-effective in refugees with moderate depressive symptoms regarding the clinical outcome and led to a reduction in direct healthcare consumption. Concerning QALYs, there was a lack of confidence that Empowerment differed from TAU. Cambridge University Press 2023-06-22 /pmc/articles/PMC10305100/ /pubmed/37345544 http://dx.doi.org/10.1192/bjo.2023.504 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited. |
spellingShingle | Paper Strupf, Michael Hoell, Andreas Bajbouj, Malek Böge, Kerem Wiechers, Maren Karnouk, Carine Kamp-Becker, Inge Banaschewski, Tobias Meyer-Lindenberg, Andreas Rapp, Michael Hasan, Alkomiet Falkai, Peter Habel, Ute Heinz, Andreas Plener, Paul Kaiser, Franziska Weigold, Stefanie Mehran, Nassim Übleis, Aline Padberg, Frank Shared sorrow, shared costs: cost-effectiveness analysis of the Empowerment group therapy approach to treat affective disorders in refugee populations |
title | Shared sorrow, shared costs: cost-effectiveness analysis of the Empowerment group therapy approach to treat affective disorders in refugee populations |
title_full | Shared sorrow, shared costs: cost-effectiveness analysis of the Empowerment group therapy approach to treat affective disorders in refugee populations |
title_fullStr | Shared sorrow, shared costs: cost-effectiveness analysis of the Empowerment group therapy approach to treat affective disorders in refugee populations |
title_full_unstemmed | Shared sorrow, shared costs: cost-effectiveness analysis of the Empowerment group therapy approach to treat affective disorders in refugee populations |
title_short | Shared sorrow, shared costs: cost-effectiveness analysis of the Empowerment group therapy approach to treat affective disorders in refugee populations |
title_sort | shared sorrow, shared costs: cost-effectiveness analysis of the empowerment group therapy approach to treat affective disorders in refugee populations |
topic | Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305100/ https://www.ncbi.nlm.nih.gov/pubmed/37345544 http://dx.doi.org/10.1192/bjo.2023.504 |
work_keys_str_mv | AT strupfmichael sharedsorrowsharedcostscosteffectivenessanalysisoftheempowermentgrouptherapyapproachtotreataffectivedisordersinrefugeepopulations AT hoellandreas sharedsorrowsharedcostscosteffectivenessanalysisoftheempowermentgrouptherapyapproachtotreataffectivedisordersinrefugeepopulations AT bajboujmalek sharedsorrowsharedcostscosteffectivenessanalysisoftheempowermentgrouptherapyapproachtotreataffectivedisordersinrefugeepopulations AT bogekerem sharedsorrowsharedcostscosteffectivenessanalysisoftheempowermentgrouptherapyapproachtotreataffectivedisordersinrefugeepopulations AT wiechersmaren sharedsorrowsharedcostscosteffectivenessanalysisoftheempowermentgrouptherapyapproachtotreataffectivedisordersinrefugeepopulations AT karnoukcarine sharedsorrowsharedcostscosteffectivenessanalysisoftheempowermentgrouptherapyapproachtotreataffectivedisordersinrefugeepopulations AT kampbeckeringe sharedsorrowsharedcostscosteffectivenessanalysisoftheempowermentgrouptherapyapproachtotreataffectivedisordersinrefugeepopulations AT banaschewskitobias sharedsorrowsharedcostscosteffectivenessanalysisoftheempowermentgrouptherapyapproachtotreataffectivedisordersinrefugeepopulations AT meyerlindenbergandreas sharedsorrowsharedcostscosteffectivenessanalysisoftheempowermentgrouptherapyapproachtotreataffectivedisordersinrefugeepopulations AT rappmichael sharedsorrowsharedcostscosteffectivenessanalysisoftheempowermentgrouptherapyapproachtotreataffectivedisordersinrefugeepopulations AT hasanalkomiet sharedsorrowsharedcostscosteffectivenessanalysisoftheempowermentgrouptherapyapproachtotreataffectivedisordersinrefugeepopulations AT falkaipeter sharedsorrowsharedcostscosteffectivenessanalysisoftheempowermentgrouptherapyapproachtotreataffectivedisordersinrefugeepopulations AT habelute sharedsorrowsharedcostscosteffectivenessanalysisoftheempowermentgrouptherapyapproachtotreataffectivedisordersinrefugeepopulations AT heinzandreas sharedsorrowsharedcostscosteffectivenessanalysisoftheempowermentgrouptherapyapproachtotreataffectivedisordersinrefugeepopulations AT plenerpaul sharedsorrowsharedcostscosteffectivenessanalysisoftheempowermentgrouptherapyapproachtotreataffectivedisordersinrefugeepopulations AT kaiserfranziska sharedsorrowsharedcostscosteffectivenessanalysisoftheempowermentgrouptherapyapproachtotreataffectivedisordersinrefugeepopulations AT weigoldstefanie sharedsorrowsharedcostscosteffectivenessanalysisoftheempowermentgrouptherapyapproachtotreataffectivedisordersinrefugeepopulations AT mehrannassim sharedsorrowsharedcostscosteffectivenessanalysisoftheempowermentgrouptherapyapproachtotreataffectivedisordersinrefugeepopulations AT ubleisaline sharedsorrowsharedcostscosteffectivenessanalysisoftheempowermentgrouptherapyapproachtotreataffectivedisordersinrefugeepopulations AT padbergfrank sharedsorrowsharedcostscosteffectivenessanalysisoftheempowermentgrouptherapyapproachtotreataffectivedisordersinrefugeepopulations |